Outcomes in patient with hospital-acquired and non-hospital-acquired SARS-CoV-2 infection
| Outcomes | No. (%)* of hospital-acquired cases n = 253 (36.3%) | No. (%)* of non-hospital-acquired cases n = 444 (63.7%) | p value |
|---|---|---|---|
| Mortality by age, yr | 99 (39.1) | 115 (25.9) | 0.001 |
| < 75 | 29 (29.6) | 23 (10.0) | |
| 75–84 | 33 (46.5) | 37 (37.0) | |
| ≥ 85 | 37 (44.1) | 55 (48.7) | |
| Hospital length of stay, median (IQR) | 25.0 (15–46) | 8 (3.5–16) | |
| Disposition at discharge† | 0.001 | ||
| Home | 74 (48.1) | 197 (59.9) | |
| Long-term care facility | 32 (20.8) | 73 (22.2) | |
| Rehabilitation | 26 (16.9) | 20 (6.1) | |
| Others‡ | 22 (14.3) | 39 (11.9) | |
| Readmission within 90 days after discharge | 24 (15.3) | 13 (4.0) | 0.001 |
Note: IQR = interquartile range, RPA = Résidence privée pour ainés (private residences for older adults).
↵* Unless stated otherwise.
↵† Disposition at discharge was calculated only for survivors (n = 154 in hospital-acquired group and n = 329 in non-hospital-acquired group).
↵‡ Others: congregate living settings such as RPA, intermediate and family-type resources (IR-FTR) and transfer to another hospital or dedicated centres for quarantine of patients with COVID-19.